2 Citations (Scopus)

Abstract

Substantial variability exists among different patients in response to drugs. The identification of genetic factors that contribute to the interpersonal differentiation has been an important task for pharmacogenetic research and drug discovery. In this article, we have derived a high-dimensional statistical model for unveiling the genetic machinery for drug response by integrating two different but biologically related processespharmacokinetics (PK) and pharmacodynamics (PD)into a genetic mapping framework. Using an integrated model of PK and PD, we can identify specific DNA sequence variants and test how they relate to the differential effect of the body to the drug (PK) and the effect of the drug on the body (PD). To effectively model a two-stage hierarchic structure of the covariance matrix at the PD and PK level, we have for the first time introduced an autoregressive moving-average (ARMA) process to the mixture-based likelihood function for sequence mapping. Closed-form estimates of the determinant and inverse of the ARMA-based covariance matrix are incorporated into the estimation step, which significantly increases the computational efficiency. Simulation studies have been performed to test the statistical behavior of our model. Potential applications of this model to pharmacogenetic research are discussed.

Original languageEnglish (US)
Pages (from-to)351-372
Number of pages22
JournalJournal of Biopharmaceutical Statistics
Volume20
Issue number2
DOIs
StatePublished - Mar 1 2010

Fingerprint

Pharmacodynamics
Moving Average Process
Autoregressive Moving Average
Pharmacokinetics
Autoregressive Process
Drugs
Pharmacogenetics
Modeling
Pharmaceutical Preparations
Covariance matrix
Likelihood Functions
Stage Structure
Drug Discovery
Integrated Model
Statistical Models
Likelihood Function
Research
DNA Sequence
Computational Efficiency
Statistical Model

All Science Journal Classification (ASJC) codes

  • Statistics and Probability
  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{200a920c13394de7bdea0b03217b7b41,
title = "Modeling the genetic etiology of pharmacokinetic-pharmacodynamic links with the ARMA process",
abstract = "Substantial variability exists among different patients in response to drugs. The identification of genetic factors that contribute to the interpersonal differentiation has been an important task for pharmacogenetic research and drug discovery. In this article, we have derived a high-dimensional statistical model for unveiling the genetic machinery for drug response by integrating two different but biologically related processespharmacokinetics (PK) and pharmacodynamics (PD)into a genetic mapping framework. Using an integrated model of PK and PD, we can identify specific DNA sequence variants and test how they relate to the differential effect of the body to the drug (PK) and the effect of the drug on the body (PD). To effectively model a two-stage hierarchic structure of the covariance matrix at the PD and PK level, we have for the first time introduced an autoregressive moving-average (ARMA) process to the mixture-based likelihood function for sequence mapping. Closed-form estimates of the determinant and inverse of the ARMA-based covariance matrix are incorporated into the estimation step, which significantly increases the computational efficiency. Simulation studies have been performed to test the statistical behavior of our model. Potential applications of this model to pharmacogenetic research are discussed.",
author = "Min Lin and Arthur Berg and Rongling Wu",
year = "2010",
month = "3",
day = "1",
doi = "10.1080/10543400903572795",
language = "English (US)",
volume = "20",
pages = "351--372",
journal = "Journal of Biopharmaceutical Statistics",
issn = "1054-3406",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

Modeling the genetic etiology of pharmacokinetic-pharmacodynamic links with the ARMA process. / Lin, Min; Berg, Arthur; Wu, Rongling.

In: Journal of Biopharmaceutical Statistics, Vol. 20, No. 2, 01.03.2010, p. 351-372.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modeling the genetic etiology of pharmacokinetic-pharmacodynamic links with the ARMA process

AU - Lin, Min

AU - Berg, Arthur

AU - Wu, Rongling

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Substantial variability exists among different patients in response to drugs. The identification of genetic factors that contribute to the interpersonal differentiation has been an important task for pharmacogenetic research and drug discovery. In this article, we have derived a high-dimensional statistical model for unveiling the genetic machinery for drug response by integrating two different but biologically related processespharmacokinetics (PK) and pharmacodynamics (PD)into a genetic mapping framework. Using an integrated model of PK and PD, we can identify specific DNA sequence variants and test how they relate to the differential effect of the body to the drug (PK) and the effect of the drug on the body (PD). To effectively model a two-stage hierarchic structure of the covariance matrix at the PD and PK level, we have for the first time introduced an autoregressive moving-average (ARMA) process to the mixture-based likelihood function for sequence mapping. Closed-form estimates of the determinant and inverse of the ARMA-based covariance matrix are incorporated into the estimation step, which significantly increases the computational efficiency. Simulation studies have been performed to test the statistical behavior of our model. Potential applications of this model to pharmacogenetic research are discussed.

AB - Substantial variability exists among different patients in response to drugs. The identification of genetic factors that contribute to the interpersonal differentiation has been an important task for pharmacogenetic research and drug discovery. In this article, we have derived a high-dimensional statistical model for unveiling the genetic machinery for drug response by integrating two different but biologically related processespharmacokinetics (PK) and pharmacodynamics (PD)into a genetic mapping framework. Using an integrated model of PK and PD, we can identify specific DNA sequence variants and test how they relate to the differential effect of the body to the drug (PK) and the effect of the drug on the body (PD). To effectively model a two-stage hierarchic structure of the covariance matrix at the PD and PK level, we have for the first time introduced an autoregressive moving-average (ARMA) process to the mixture-based likelihood function for sequence mapping. Closed-form estimates of the determinant and inverse of the ARMA-based covariance matrix are incorporated into the estimation step, which significantly increases the computational efficiency. Simulation studies have been performed to test the statistical behavior of our model. Potential applications of this model to pharmacogenetic research are discussed.

UR - http://www.scopus.com/inward/record.url?scp=77951274759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951274759&partnerID=8YFLogxK

U2 - 10.1080/10543400903572795

DO - 10.1080/10543400903572795

M3 - Article

C2 - 20309763

AN - SCOPUS:77951274759

VL - 20

SP - 351

EP - 372

JO - Journal of Biopharmaceutical Statistics

JF - Journal of Biopharmaceutical Statistics

SN - 1054-3406

IS - 2

ER -